Friday, 11 July 2014

Can people with type 2 diabetes live longer than people without diabetes? 

Patients with type 2 diabetes initiated with metformin monotherapy had longer survival than did matched, non-diabetic controls. Those treated with sulfonylurea had markedly reduced survival than both matched controls and those receiving metformin monotherapy. This supports the position of metformin as first-line therapy and implies that metformin may confer benefit in non-diabetes. Sulfonylurea remains a continued concern (Diabetes, Obesity and Metabolism)

No comments:

Post a Comment